Posts Categorized: About the Opioid Crisis

I attempted to write this blog about half a dozen times. Feeling an overwhelming resistance, I’d sit at my desk, type a few words, delete them, then try again. When the flow didn’t materialize, I told myself, “I’ll do it tomorrow.” Ten days later, I still  hadn’t written the blog. What was my problem? Drugs…

There’s a scene in my novel, Busted, where the main character decides to try cocaine. Not having used cocaine myself, I interviewed several people to understand their experience. Out of concern for making blow sound desirable, I hesitated to describe the main character’s experience. I feel the same way about this blog. On Saturday, March…

My generation was part of the “hippie” movement: the free-love, LSD-taking, marijuana-smoking, counter-culture allure that spanned the U.S. in the 1960’s. Forty years later… An article by Peter Rowe in the Los Angeles Times on Sunday, February 18th stated that from 2006 to 2013, the National Survey on Drug Use and Health reported a 250%…

According to an article in Sunday’s December 17th, 2017 Los Angeles Times, the legalized marijuana industry is projected to grow to $7 billion by 2002. In preparation, California, banks, and federal regulators are working together to create a “green banking system.”   Under this new system, one bank would be designated as a central repository…

The following updates are from the Drug Policy Alliance. Thought you might enjoy hearing about positive progress. The Rohrabacher-Blumenauer Amendment, which prevents the Justice Department from using federal funds to interfere with state medical marijuana programs, was approved until December 22, when federal spending will be revisited. (The legislation was tacked onto the federal funding…

Did you watch the 60 Minutes segment about the opioid crisis on October 15th, 2017? In case you missed it, 60 Minutes correspondent Bill Whitaker interviewed ex-DEA Agent Joe Rannazzisi, who ran the DEA’s Office of Diversion Control that regulates and investigates the pharmaceutical industry. Rannazzisi, a whistleblower, said the opioid crisis was allowed to…

In response to my September 26, 2017 blog about Modernizing Marijuana Retail Stores, my friend Lea Claveran shared that she is using a CBD-based skin care product called CRAVE. CBD, also known as canabinoid cannabidiol, is one of the most prevalent chemical compounds in marijuana and comes in oils, edibles, vapes, and flowers. In case…

On Thursday, July 27th, 2017 the Senate Appropriations Committee renewed an amendment which protects medical marijuana from federal interference. In other words, marijuana patients and providers cannot be prosecuted. The amendment had bipartisan support and passed with voice votes–which are used for non-controversial issues. The next step is for the amendment to be included in the final appropriations bill,…